The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| EXELIXIS INC | COM | 30161Q104 | 359,249 | 15,094,495 | SH | SOLE | 15,094,495 | 0 | 0 | ||
| ALKERMES PLC | SHS | G01767105 | 32,564 | 892,400 | SH | SOLE | 892,400 | 0 | 0 | ||
| CELLDEX THERAPEUTICS | COM | 15117B103 | 2,071 | 420,846 | SH | SOLE | 420,846 | 0 | 0 | ||
| WISDOMTREE INDIA EARNINGS FUND | COM | 97717W422 | 10,532 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
| ISHARES MSCI INDIA ETF | COM | 46429B598 | 11,280 | 320,000 | SH | SOLE | 320,000 | 0 | 0 | ||
| ESPERION THERAPEUTICS INC | COM | 29664W105 | 107,595 | 2,679,835 | SH | SOLE | 2,679,835 | 0 | 0 | ||
| PROSHARES ULTRAPRO SHORT QQQ ETF | SHS | 74348A160 | 2,898 | 285,000 | SH | SOLE | 2,898 | 0 | 0 | ||
| PROSHARES ULTRASHORT S&P 500 ETF | SHS | 74347B383 | 3,828 | 115,000 | SH | SOLE | 3,828 | 0 | 0 | ||
| PROSHARES ULTRAPRO SHORT S&P 500 ETF | SHS | 74347B268 | 3,312 | 105,000 | SH | SOLE | 3,312 | 0 | 0 | ||